Search results
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoMyriad Genetics, Inc. (NASDAQ:MYGN) Q1 2024 Earnings Call Transcript May 7, 2024 Myriad Genetics,...
Myriad Genetics First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 16 hours agoMyriad Genetics (NASDAQ:MYGN) First Quarter 2024 Results Key Financial Results Revenue: US$202.2m...
Myriad Genetics (MYGN) Posts Narrower-Than-Estimate Loss in Q1
Zacks via Yahoo Finance· 1 day agoMyriad Genetics (MYGN) first-quarter average revenue per test across its product portfolio benefited...
Analyst Report: Myriad Genetics, Inc.
Morningstar Research via Yahoo Finance· 1 day agoMyriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual’s risk of developing a disease. The firm ...
Myriad Genetics, Inc. [NASDAQ: MYGN] Sees Increase in Stock Value – Knox Daily
Knox Daily· 20 hours agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Myriad Genetics, Inc. shares valued at $572,835 were ...
Myriad Genetics Reports Q1 2024 Earnings: Revenue Growth Surpasses Estimates Amidst Challenges
GuruFocus.com via Yahoo Finance· 2 days agoOperational Developments: Announced the reorganization of European operations and the sale of the...
Myriad Genetics (NASDAQ:MYGN) shareholders have endured a 26% loss from investing in the stock five...
Simply Wall St. via Yahoo Finance· 3 days agoIdeally, your overall portfolio should beat the market average. But in any portfolio, there will be...
Myriad Genetics, Inc. (MYGN) Stock: Evaluating the Market Performance – News Heater
NewsHeater· 1 day agoMoreover, the 36-month beta value for MYGN is 1.94. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 2 as “overweight,” 9 as “hold,” and 3 as “sell.” The public float for MYGN is 86.02M and currently, short sellers
Myriad Genetics Inc (MYGN) Q1 2024 Earnings Call Transcript Highlights: Strong Start with ...
GuruFocus.com via Yahoo Finance· 2 days agoExplore key insights from Myriad Genetics' Q1 2024 earnings, featuring significant revenue increases and strategic initiatives aimed at enhancing market position.
Yousif Capital Management LLC Buys 3,195 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
ETF DAILY NEWS· 5 days agoYousif Capital Management LLC raised its stake in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 7.8% in the fourth quarter, according to ...
